Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Everitt

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy PlanningBelinda A Campbell, Jason Callahan, Mathias Bressel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Dose-Response Relationships Between Radiation Exposure, Bone Marrow Function as Measured by <sup>18</sup>F-Fluorothymidine Positron Emission Tomography, and Lymphocyte Counts During Chemoradiation for Non-Small Cell Lung CancerMichael P MacManus, Elizabeth Prins, Jing Xie, et al.
Cancer|July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancerSarah Everitt, Alan Herschtal, Jason Callahan, et al.
Journal of Medical Imaging and Radiation Oncology|July 28, 2021
Nodal metabolic tumour volume on baseline <sup>18</sup> F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapyRamin Alipour, Nick Bucknell, Mathias Bressel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2016
Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocolTom Konert, Wouter V Vogel, Sarah Everitt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival dataMichael P Mac Manus, Sarah Everitt, Mike Bayne, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2021
Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centresJean-Pierre Bissonnette, Alexander Sun, Inga S Grills, et al.
Plos One|February 26, 2020
Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?Tom Konert, Sarah Everitt, Matthew D La Fontaine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2013
The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancerSarah Everitt, Nikki Plumridge, Alan Herschtal, et al.
NPJ Precision Oncology|April 8, 2022
Imaging immunity in patients with cancer using positron emission tomographyFiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy PlanningBelinda A Campbell, Jason Callahan, Mathias Bressel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2024
Dose-Response Relationships Between Radiation Exposure, Bone Marrow Function as Measured by <sup>18</sup>F-Fluorothymidine Positron Emission Tomography, and Lymphocyte Counts During Chemoradiation for Non-Small Cell Lung CancerMichael P MacManus, Elizabeth Prins, Jing Xie, et al.
Cancer|July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancerSarah Everitt, Alan Herschtal, Jason Callahan, et al.
Journal of Medical Imaging and Radiation Oncology|July 28, 2021
Nodal metabolic tumour volume on baseline <sup>18</sup> F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapyRamin Alipour, Nick Bucknell, Mathias Bressel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2016
Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocolTom Konert, Wouter V Vogel, Sarah Everitt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival dataMichael P Mac Manus, Sarah Everitt, Mike Bayne, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2021
Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centresJean-Pierre Bissonnette, Alexander Sun, Inga S Grills, et al.
Plos One|February 26, 2020
Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?Tom Konert, Sarah Everitt, Matthew D La Fontaine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2013
The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancerSarah Everitt, Nikki Plumridge, Alan Herschtal, et al.
NPJ Precision Oncology|April 8, 2022
Imaging immunity in patients with cancer using positron emission tomographyFiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, et al.
Pageof 4